300 related articles for article (PubMed ID: 16622266)
21. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
Huber RM; Flentje M; Schmidt M; Pöllinger B; Gosse H; Willner J; Ulm K;
J Clin Oncol; 2006 Sep; 24(27):4397-404. PubMed ID: 16983107
[TBL] [Abstract][Full Text] [Related]
23. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P
Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
[TBL] [Abstract][Full Text] [Related]
24. Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma.
Atchariyasathian V; Pruegsanusak K; Wongsriwattanakul S
J Laryngol Otol; 2015 Aug; 129(8):767-72. PubMed ID: 26112091
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma.
Demizu Y; Sasaki R; Soejima T; Maruta T; Okamoto Y; Yamada K; Yoden E; Ejima Y; Ota Y; Ishida H; Nibu K; Sugimura K
Jpn J Clin Oncol; 2006 Oct; 36(10):620-5. PubMed ID: 16905756
[TBL] [Abstract][Full Text] [Related]
26. Late complications of radiotherapy for nasopharyngeal carcinoma.
Sumitsawan Y; Chaiyasate S; Chitapanarux I; Anansuthiwara M; Roongrotwattanasiri K; Vaseenon V; Tooncam H
Auris Nasus Larynx; 2009 Apr; 36(2):205-9. PubMed ID: 18635325
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract][Full Text] [Related]
28. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
29. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
[TBL] [Abstract][Full Text] [Related]
30. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.
Chan AT; Leung SF; Ngan RK; Teo PM; Lau WH; Kwan WH; Hui EP; Yiu HY; Yeo W; Cheung FY; Yu KH; Chiu KW; Chan DT; Mok TS; Yau S; Yuen KT; Mo FK; Lai MM; Ma BB; Kam MK; Leung TW; Johnson PJ; Choi PH; Zee BC
J Natl Cancer Inst; 2005 Apr; 97(7):536-9. PubMed ID: 15812080
[TBL] [Abstract][Full Text] [Related]
31. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
32. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
33. Nasal irrigation reduces postirradiation rhinosinusitis in patients with nasopharyngeal carcinoma.
Liang KL; Kao TC; Lin JC; Tseng HC; Su MC; Hsin CH; Shiao JY; Jiang RS
Am J Rhinol; 2008; 22(3):258-62. PubMed ID: 18588757
[TBL] [Abstract][Full Text] [Related]
34. Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
Zuur CL; Simis YJ; Verkaik RS; Schornagel JH; Balm AJ; Dreschler WA; Rasch CR
Radiother Oncol; 2008 Oct; 89(1):38-43. PubMed ID: 18706728
[TBL] [Abstract][Full Text] [Related]
35. Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns.
Kew J; King AD; Leung SF; Tong MC; Ku PK; Wong KK; van Hasselt CA
Am J Otol; 2000 Nov; 21(6):782-5. PubMed ID: 11078063
[TBL] [Abstract][Full Text] [Related]
36. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
37. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
[TBL] [Abstract][Full Text] [Related]
38. Results of combined modality treatment for nasopharyngeal cancer.
Venkitaraman R; Ramanan SG; Vasanthan A; Sagar TG
J Cancer Res Ther; 2009; 5(2):102-6. PubMed ID: 19542665
[TBL] [Abstract][Full Text] [Related]
39. Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.
Liberman PH; Schultz C; Gomez MV; Carvalho AL; Pellizzon AC; Testa JR; Feher O; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1265-8. PubMed ID: 15545579
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcome of locally advanced nasopharyngeal cancer with concurrent chemoradiotherapy.
Yarney J; Vanderpuye V; Kitcher ED
West Afr J Med; 2008 Apr; 27(2):65-8. PubMed ID: 19025016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
